RU94003002A - Method of prolongation of thymolol therapeutic action - Google Patents

Method of prolongation of thymolol therapeutic action

Info

Publication number
RU94003002A
RU94003002A RU94003002/14A RU94003002A RU94003002A RU 94003002 A RU94003002 A RU 94003002A RU 94003002/14 A RU94003002/14 A RU 94003002/14A RU 94003002 A RU94003002 A RU 94003002A RU 94003002 A RU94003002 A RU 94003002A
Authority
RU
Russia
Prior art keywords
thymolol
therapeutic action
prolongation
timolol
hyaluronic acid
Prior art date
Application number
RU94003002/14A
Other languages
Russian (ru)
Other versions
RU2089191C1 (en
Inventor
Л.И. Стекольников
И.И. Самойленко
А.А. Корнилова
Original Assignee
Научно-производственная фирма "Нарт"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-производственная фирма "Нарт" filed Critical Научно-производственная фирма "Нарт"
Priority to RU94003002A priority Critical patent/RU2089191C1/en
Publication of RU94003002A publication Critical patent/RU94003002A/en
Application granted granted Critical
Publication of RU2089191C1 publication Critical patent/RU2089191C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FIELD: medicine. SUBSTANCE: invention relates to prolongation of thymolol therapeutic action that is one of noncardioselective β---adrenoblocking agent used for glaucoma treatment. Method involves the use of thymolol in combination with hyaluronic acid. Thymolol and hyaluronic acid were taken at mass ratio 1:(2-4) at solution concentration containing this mixture 0.01-0.05%. EFFECT: decreased thymolol dose, prolonged therapeutic action with respect to intraocular pressure decrease.

Claims (1)

Изобретение решает задачу уменьшения дозы тимолола и пролонгации его способности снижать внутриглазное давление. Указанный результат достигается тем, что в способе пролонгации терапевтического эффекта тимолола, включающем использование тимолола в комбинации с соединениями, усиливающими его способность снижать внутриглазное давление, в качестве соединения, усиливающего специфическое действие тимолола, используют гиалуроновую кислоту, при этом тимолол и гиалуроновую кислоту берут в массовом соотношении 1:2 - 4, а концентрация раствора, содержащего эту комбинацию, составляет 0,01 - 0,05%.The invention solves the problem of reducing the dose of timolol and prolonging its ability to reduce intraocular pressure. This result is achieved by the fact that in the method of prolonging the therapeutic effect of timolol, including the use of timolol in combination with compounds that enhance its ability to reduce intraocular pressure, hyaluronic acid is used as a compound that enhances the specific effect of timolol, while timolol and hyaluronic acid are taken in bulk a ratio of 1: 2 - 4, and the concentration of the solution containing this combination is 0.01 - 0.05%.
RU94003002A 1994-01-28 1994-01-28 Method of prolongation of physiological effect of thymolol with respect to intraocular pressure decreasing RU2089191C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94003002A RU2089191C1 (en) 1994-01-28 1994-01-28 Method of prolongation of physiological effect of thymolol with respect to intraocular pressure decreasing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94003002A RU2089191C1 (en) 1994-01-28 1994-01-28 Method of prolongation of physiological effect of thymolol with respect to intraocular pressure decreasing

Publications (2)

Publication Number Publication Date
RU94003002A true RU94003002A (en) 1996-08-10
RU2089191C1 RU2089191C1 (en) 1997-09-10

Family

ID=20151856

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94003002A RU2089191C1 (en) 1994-01-28 1994-01-28 Method of prolongation of physiological effect of thymolol with respect to intraocular pressure decreasing

Country Status (1)

Country Link
RU (1) RU2089191C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034371A1 (en) * 2001-06-08 2004-02-18 Novartis Ag PHARMACEUTICAL COMPOSITIONS
US20030018382A1 (en) * 2001-07-17 2003-01-23 Pflugfelder Stephen C. Process for improving vision

Also Published As

Publication number Publication date
RU2089191C1 (en) 1997-09-10

Similar Documents

Publication Publication Date Title
AU1537095A (en) Therapeutic agents containing thyroid hormones
AU7880991A (en) A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
RU94041223A (en) Agent for motoneuron disease treatment
DE69514813D1 (en) Bicyclische diarylheterocyclen als cyclooxygenase-2-inhibitoren
FR2415112A1 (en) NEW SPIROTHIENOHYDANTOINS DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
RU95113862A (en) Pyrrolopyrimidine derivatives, pharmaceutical composition, intermediate compounds
HUT51136A (en) Process for producing pharmaceutical compositions for treating schisophreny, containing l-deprenil as active component
EA199800043A1 (en) SUBSTITUTED (SULPHINIC ACID, SULPHONIC ACID, SULPHONYLAMINO OR SULPHINYLAMINO) N - [(AMINOIMINOMETHYL) PHENYALKYL] AZHETHEROCYCLYL-AMIDE DERIVATIVE
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
EA199800690A1 (en) SUBSTITUTED N - [(AMINOIMINOMETHYL) PHENYLALKYL] AZHGETHROCYLAMIDE OF SULPHONIC ACIDS
AU6698894A (en) 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
KR950007848A (en) Treatment of Anxiety with (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide
ES8607916A1 (en) Biscarboxamides for treating diseases, and process for their preparation.
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
RU94003002A (en) Method of prolongation of thymolol therapeutic action
GB1474424A (en) Pharmaceutical composition for treating diabetic ketoacidosis
DE3750464D1 (en) Pharmaceutical preparation for the treatment of cataracts.
RU98101105A (en) NEW APPLICATION FOR MEDICAL PURPOSES
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
RU2001122151A (en) DRUG FOR TREATMENT OF ACUTE POST-NENAL ENDOMETRITIS IN COWS AND METHOD OF ITS APPLICATION
JPS59210040A (en) Method for stabilizing hinokitiol
KR920009403A (en) Imidazobenzodiazepine for sleep disorder treatment
US3449499A (en) Method for the reduction of glycemia
SU1528496A1 (en) Dehydration agent
RU94025799A (en) Method of treatment of idiopathic dermatomyositis